08 Jul, 2016 J&J and Janssen Hit With $70 Million Risperdal Verdict By Andrew Steinberg | Current Litigation & Lawsuit News,Dangerous Prescription Drug | 0 Comments Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, were ordered to pay a Tennessee man and his family $70 million in the fifth Risperdal lawsuit to go to trial... Read More
